Review meeting: Drug board registers 200 new products

Source: Tribune

The board discussed various cases pertaining to registration and quality control of pharmaceutical and medical devices by the local manufacturers as well as imported products, a press release stated.

ISLAMABAD:The drug registration board has approved around 200 products along with an application for a new drug, Sofosbuvir Tablet — recently introduced therapy for the treatment of Hepatitis C.

These decisions were taken on Tuesday after a two-day meeting of the board held at the Ministry of National Health Serivces, Regulations and Coordination under the chairmanship of Director Pharmaceutical Evaluation and Registration Ghulam Rasool Dutani.

The board discussed various cases pertaining to registration and quality control of pharmaceutical and medical devices by the local manufacturers as well as imported products, a press release stated.

It also considered cases of substandard drugs and suspended registrations of two products after hearing these manufacturers and issued final notices to six manufacturers for being involved in the manufacturing of substandard drugs. The board gave directions to recall all such batches from the market.

 

This entry was posted in Hepatitis C, Sofosbuvir. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s